Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial.
HBV vaccination is recommended in HIV-infected adults with CD4+ cell count >200/mm(3) although the efficacy is only 33.3% -65%. We conducted a randomized, controlled trial to evaluate the efficacy and safety of three regimens of HBV vaccination at Chiang Mai University Hospital, Thailand.From Feb...
Main Authors: | Kanokporn Chaiklang, Jiraprapa Wipasa, Romanee Chaiwarith, Jutarat Praparattanapan, Khuanchai Supparatpinyo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3827227?pdf=render |
Similar Items
-
Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
by: Romanee Chaiwarith, et al.
Published: (2019-11-01) -
Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
by: Nattinee Laksananun, et al.
Published: (2019-05-01) -
Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
by: Panuwat Wongkulab, et al.
Published: (2013-01-01) -
Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.
by: Jiraprapa Wipasa, et al.
Published: (2014-01-01) -
Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
by: Romanee Chaiwarith, et al.
Published: (2023-11-01)